Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.41 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.44.
Market Cap
9.41T
Revenue
4.66T
Profits
186.61B
PE Ratio
50.44
Profit Margin
4.00%
Dividend Yield
0.37%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | -0.98% | 1,261,625 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 643.33B | 0.45% | 3,461,213 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 452.61B | -0.78% | 1,737,750 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 365.41B | -0.96% | 4,837,129 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 354.05B | -0.15% | 1,619,729 | 450.53B |
| 6 | NVS | Novartis AG | 294.79B | -0.84% | 808,685 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.73B | -1.14% | 1,547,414 | 61.37B |
| 8 | AMGN | Amgen Inc. | 233.43B | -1.19% | 983,399 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 229.96B | -1.39% | 137,847 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 203.54B | -1.62% | 6,363,830 | 50.34B |
| 11 | ABT | Abbott Laboratories | 194.84B | 0.91% | 4,982,674 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 180.30B | -2.32% | 2,125,879 | 30.46B |
| 13 | PFE | Pfizer Inc. | 158.85B | -0.54% | 15,575,305 | 63.70B |
| 14 | DHR | Danaher Corporation | 152.14B | 0.34% | 1,918,239 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 137.36B | -1.02% | 375,538 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 135.80B | -0.70% | 2,817,739 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.71B | 1.56% | 752,868 | 11.03B |
| 18 | SYK | Stryker Corporation | 127.19B | 2.94% | 1,267,827 | 25.84B |
| 19 | CVS | CVS Health Corporation | 119.25B | 0.34% | 2,425,081 | 412.65B |
| 20 | MDT | Medtronic plc | 116.93B | 1.53% | 3,410,833 | 36.36B |
| 21 | SNY | Sanofi | 107.86B | -0.22% | 1,102,442 | 55.89B |
| 22 | MCK | McKesson Corporation | 104.20B | 0.36% | 363,240 | 410.98B |
| 23 | GSK | GSK plc | 100.84B | 0.84% | 2,307,070 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 90.56B | -0.26% | 555,045 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.06B | -0.58% | 277,395 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.37B | -1.59% | 285,630 | 15.53B |
| 27 | CI | The Cigna Group | 73.70B | 0.45% | 392,306 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 67.78B | 0.21% | 9,740,253 | 21.00B |
| 29 | ARGX | argenx SE | 64.97B | -3.29% | 124,386 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.32B | 0.03% | 338,217 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 57.89B | 0.03% | 1,469,519 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 54.76B | -3.94% | 22,610,265 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.63B | -0.10% | 661,078 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.98B | 0.26% | 976,055 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.78B | 1.05% | 301,927 | 22.48B |
| 36 | NTRA | Natera, Inc. | 47.18B | -3.37% | 155,876 | 2.71B |
| 37 | HUM | Humana Inc. | 46.81B | -0.72% | 355,467 | 145.68B |
| 38 | MDLN | Medline Inc. | 46.50B | 2.08% | 4,427,120 | 29.94B |
| 39 | VEEV | Veeva Systems Inc. | 44.87B | -1.77% | 1,287,782 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.65B | -5.81% | 1,470,546 | - |
| 41 | HLN | Haleon plc | 44.23B | 0.55% | 6,769,633 | 14.80B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 43.72B | 1.80% | 53,126 | 4.55B |
| 43 | A | Agilent Technologies, Inc. | 43.68B | -1.76% | 1,571,858 | 7.37B |
| 44 | IQV | IQVIA Holdings Inc. | 43.02B | -0.38% | 1,378,033 | 16.98B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 42.49B | -3.08% | 2,123,635 | 17.32B |
| 46 | ONC | BeOne Medicines AG | 41.57B | -1.85% | 30,599 | 6.13B |
| 47 | WAT | Waters Corporation | 40.97B | -1.01% | 268,060 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.16B | -0.42% | 733,958 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 34.95B | -1.84% | 1,025,885 | 2.54B |
| 50 | RMD | ResMed Inc. | 34.64B | 1.86% | 845,981 | 5.65B |
| 51 | DXCM | DexCom, Inc. | 34.23B | 1.58% | 1,599,679 | 4.97B |
| 52 | ILMN | Illumina, Inc. | 32.70B | -4.90% | 1,207,105 | 4.49B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 32.45B | -0.88% | 1,176,073 | 21.27B |
| 54 | CNC | Centene Corporation | 32.27B | -0.02% | 1,568,218 | 180.30B |
| 55 | BIIB | Biogen Inc. | 32.19B | -1.65% | 276,573 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 32.01B | 3.26% | 3,039,466 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.58B | -0.24% | 1,323,809 | 4.80B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.04B | -0.58% | 85,275 | 4.13B |
| 59 | LH | Labcorp Holdings Inc. | 27.25B | -0.17% | 65,586 | 14.35B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.81B | -0.69% | 253,957 | 11.56B |
| 61 | PHG | Koninklijke Philips N.V. | 26.18B | -0.67% | 440,226 | 20.18B |
| 62 | INSM | Insmed Incorporated | 25.90B | -2.30% | 1,464,474 | 1.14B |
| 63 | BNTX | BioNTech SE | 25.78B | -7.86% | 2,638,106 | 3.03B |
| 64 | ROIV | Roivant Sciences Ltd. | 25.42B | -6.36% | 5,381,216 | 7.53M |
| 65 | INCY | Incyte Corporation | 25.06B | -3.22% | 612,646 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.80B | -2.29% | 222,594 | 3.33B |
| 67 | STE | STERIS plc | 22.76B | 0.20% | 208,872 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.15B | -2.17% | 161,935 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 21.86B | -3.32% | 1,112,734 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.48B | -0.35% | 88,198 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.17B | -2.76% | 956,094 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.30B | 1.70% | 520,845 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.91B | -2.55% | 3,742,493 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.79B | -1.63% | 126,358 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.26B | -0.72% | 201,453 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.94B | -2.19% | 1,024,987 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.61B | -1.53% | 439,600 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.57B | 0.56% | 345,928 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 15.00B | -2.49% | 1,335,717 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.35B | -0.86% | 903,725 | 2.91B |
| 81 | COO | The Cooper Companies, Inc. | 13.94B | 0.73% | 525,552 | 4.23B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.88B | -1.92% | 385,298 | 4.00B |
| 83 | BAX | Baxter International Inc. | 13.58B | 1.33% | 2,022,824 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.51B | -1.36% | 677,000 | 2.44B |
| 85 | ICLR | ICON Public Limited Company | 13.09B | -0.05% | 168,056 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.67B | 0.23% | 98,261 | 1.50B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.48B | -1.23% | 651,676 | 3.41B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.41B | -1.86% | 553,118 | 830.81M |
| 89 | FMS | Fresenius Medical Care AG | 12.39B | -0.88% | 565,748 | 22.19B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | -1.51% | 177,811 | 1.28B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 12.34B | -2.71% | 954,055 | 14.37B |
| 92 | SNN | Smith & Nephew plc | 12.12B | -0.55% | 1,316,129 | 6.30B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.11B | -1.00% | 2,080,107 | 5.02B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.02B | -3.93% | 859,098 | 669.50M |
| 95 | EHC | Encompass Health Corporation | 11.95B | 1.30% | 591,704 | 6.21B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 11.94B | -1.57% | 843,740 | 1.66B |
| 97 | TEM | Tempus AI, Inc. | 11.59B | -9.11% | 7,064,930 | 1.43B |
| 98 | DVA | DaVita Inc. | 11.58B | 1.49% | 258,887 | 14.01B |
| 99 | TECH | Bio-Techne Corporation | 11.35B | -0.10% | 1,177,674 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 11.23B | -0.43% | 629,213 | 4.14B |
| 101 | GMED | Globus Medical, Inc. | 11.19B | 1.02% | 729,725 | 3.14B |
| 102 | SMMT | Summit Therapeutics Inc. | 10.96B | -4.12% | 2,626,694 | - |
| 103 | GKOS | Glaukos Corporation | 10.63B | -0.89% | 209,520 | 612.84M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.58B | -0.89% | 681,974 | 5.67M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.49B | -2.89% | 283,655 | 776.57M |
| 106 | MOH | Molina Healthcare, Inc. | 10.48B | 1.25% | 505,042 | 42.47B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.38B | -0.42% | 116,821 | 2.59B |
| 108 | KRYS | Krystal Biotech, Inc. | 10.37B | -2.01% | 91,667 | 440.48M |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.27B | -0.08% | 1,039,744 | 3.50B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.01% | 244,706 | - |
| 111 | UHS | Universal Health Services, Inc. | 10.11B | -0.63% | 365,240 | 18.11B |
| 112 | IONS | Ionis Pharmaceuticals, Inc. | 10.11B | -2.59% | 1,082,198 | 874.09M |
| 113 | PODD | Insulet Corporation | 10.09B | 1.46% | 545,140 | 3.05B |
| 114 | CYTK | Cytokinetics, Incorporated | 10.07B | -7.05% | 3,455,948 | 67.67M |
| 115 | HSIC | Henry Schein, Inc. | 10.01B | -0.53% | 377,397 | 13.60B |
| 116 | ENSG | The Ensign Group, Inc. | 10.00B | -0.28% | 48,980 | 5.49B |
| 117 | RGEN | Repligen Corporation | 9.96B | -3.08% | 464,775 | 785.10M |
| 118 | AVTR | Avantor, Inc. | 9.90B | 0.14% | 2,785,492 | 6.56B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.84B | -1.54% | 245,026 | 105.00M |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 9.70B | -5.53% | 179,089 | 7.46M |
| 121 | OSCR | Oscar Health, Inc. | 9.62B | 3.83% | 3,481,026 | 15.32B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.33B | -3.56% | 338,883 | 281.99M |
| 123 | TWST | Twist Bioscience Corporation | 9.02B | -6.09% | 975,189 | 431.80M |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.01% | 480,491 | 42.16M |
| 125 | PCVX | Vaxcyte, Inc. | 8.94B | -1.82% | 414,794 | - |
| 126 | QGEN | Qiagen N.V. | 8.92B | -1.35% | 868,928 | 2.10B |
| 127 | BRKR | Bruker Corporation | 8.69B | -3.73% | 1,217,559 | 3.50B |
| 128 | IBRX | ImmunityBio, Inc. | 8.58B | -3.63% | 5,958,119 | 165.79M |
| 129 | IMVT | Immunovant, Inc. | 8.52B | -5.82% | 539,442 | - |
| 130 | ATR | AptarGroup, Inc. | 8.46B | 0.14% | 59,879 | 3.93B |
| 131 | HQY | HealthEquity, Inc. | 8.02B | 3.84% | 1,504,282 | 1.36B |
| 132 | ALKS | Alkermes plc | 8.01B | -2.37% | 664,074 | 1.67B |
| 133 | TXG | 10x Genomics, Inc. | 8.01B | -5.26% | 1,568,903 | 616.91M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.97B | -3.42% | 725,582 | - |
| 135 | TGTX | TG Therapeutics, Inc. | 7.72B | -2.33% | 605,118 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.42B | -4.27% | 50,168 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.26B | -2.56% | 2,555,179 | 989.61M |
| 138 | HNGE | Hinge Health, Inc. | 7.11B | -5.09% | 1,385,606 | 720.06M |
| 139 | SRRK | Scholar Rock Holding Corporation | 7.02B | -2.77% | 151,294 | - |
| 140 | GRFS | Grifols, S.A. | 7.00B | -1.21% | 239,815 | 8.48B |
| 141 | CHE | Chemed Corporation | 6.83B | 0.89% | 109,811 | 2.60B |
| 142 | PACS | PACS Group, Inc. | 6.82B | -2.60% | 281,801 | 5.55B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.68B | -9.57% | 10,827,890 | 2.58B |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.39% | 947,061 | 1.56B |
| 145 | CGON | CG Oncology, Inc. | 6.57B | -6.13% | 289,423 | 6.23M |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.34B | -2.09% | 216,844 | 618.07M |
| 147 | ERAS | Erasca, Inc. | 6.34B | -7.03% | 1,670,190 | - |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.23B | -2.10% | 496,586 | 591.33M |
| 149 | ORKA | Oruka Therapeutics, Inc. | 6.14B | -3.95% | 366,884 | - |
| 150 | LQDA | Liquidia Corporation | 6.13B | -2.07% | 599,874 | 450.91M |
| 151 | BLCO | Bausch + Lomb Corporation | 6.13B | 0.12% | 272,488 | 5.32B |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.12B | -2.39% | 650,766 | 3.12B |
| 153 | BLTE | Belite Bio, Inc | 6.11B | -3.29% | 17,048 | - |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.07B | -2.43% | 317,844 | 840.85M |
| 155 | COGT | Cogent Biosciences, Inc. | 6.01B | -6.58% | 1,078,674 | - |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.97B | -4.33% | 57,519 | 1.90M |
| 157 | TFX | Teleflex Incorporated | 5.95B | 1.91% | 120,970 | 2.25B |
| 158 | RDNT | RadNet, Inc. | 5.94B | 0.08% | 270,090 | 2.27B |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.83B | -2.76% | 384,418 | 1.01B |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | -2.84% | 366,413 | 7.50M |
| 161 | STVN | Stevanato Group S.p.A. | 5.75B | -5.65% | 248,194 | 1.40B |
| 162 | MMED | MiniMed Group, Inc. | 5.66B | 3.38% | 925,359 | 3.10B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.60B | -2.51% | 990,221 | 13.39M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.57B | -1.79% | 75,169 | 290.54M |
| 165 | SHC | Sotera Health Company | 5.53B | -0.56% | 623,411 | 1.22B |
| 166 | DFTX | Definium Therapeutics, Inc. | 5.51B | -6.50% | 1,291,435 | - |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.41B | 1.13% | 199,227 | 1.58B |
| 168 | WAY | Waystar Holding Corp. | 5.03B | 3.92% | 1,235,943 | 1.21B |
| 169 | ACAD | ACADIA Pharmaceuticals Inc. | 5.02B | -2.05% | 990,926 | 1.14B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.85B | -0.10% | 217,549 | 148.00K |
| 171 | HAE | Haemonetics Corporation | 4.73B | -0.96% | 90,048 | 1.35B |
| 172 | DOCS | Doximity, Inc. | 4.72B | 3.52% | 2,196,930 | 655.57M |
| 173 | LFST | LifeStance Health Group, Inc. | 4.71B | 0.33% | 2,501,106 | 1.58B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.68B | -2.56% | 474,455 | - |
| 175 | DYN | Dyne Therapeutics, Inc. | 4.66B | -4.45% | 545,619 | - |
| 176 | BLLN | BillionToOne, Inc. | 4.42B | -1.48% | 291,391 | 397.41M |
| 177 | LIVN | LivaNova PLC | 4.41B | 0.05% | 250,226 | 1.47B |
| 178 | ICUI | ICU Medical, Inc. | 4.40B | 0.41% | 90,210 | 2.16B |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.38B | -0.98% | 244,494 | 2.29B |
| 180 | NVST | Envista Holdings Corporation | 4.37B | -0.77% | 731,777 | 2.86B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.35B | -6.71% | 844,371 | -665.00K |
| 182 | CELC | Celcuity Inc. | 4.34B | -4.98% | 252,952 | - |
| 183 | ITGR | Integer Holdings Corporation | 4.26B | 0.07% | 62,881 | 1.84B |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.25B | -4.02% | 350,339 | - |
| 185 | HTFL | HeartFlow, Inc. | 4.14B | -1.04% | 877,192 | 212.07M |
| 186 | RLAY | Relay Therapeutics, Inc. | 4.13B | -3.04% | 1,787,663 | 10.35M |
| 187 | MANE | Veradermics, Incorporated | 4.09B | -3.93% | 347,419 | - |
| 188 | INDV | Indivior Pharmaceuticals, Inc. | 4.08B | -2.04% | 1,429,466 | 1.33B |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 4.05B | -4.08% | 989,601 | 308.08M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.98B | -6.65% | 1,100,969 | 53.81M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.97B | 3.58% | 277,969 | 825.34M |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.87B | -3.90% | 486,561 | 234.13M |
| 193 | LEGN | Legend Biotech Corporation | 3.87B | -2.68% | 702,718 | 1.27B |
| 194 | DNLI | Denali Therapeutics Inc. | 3.83B | -2.80% | 468,205 | 3.60M |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.82B | -0.75% | 71,373 | 890.79M |
| 196 | VKTX | Viking Therapeutics, Inc. | 3.76B | -4.90% | 1,750,654 | - |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.74B | -4.07% | 619,347 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.69B | -8.15% | 4,804,287 | 66.17M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.65B | -2.54% | 5,466,069 | 324.97M |
| 200 | OGN | Organon & Co. | 3.61B | 0.04% | 1,897,196 | 6.13B |
| 201 | OPCH | Option Care Health, Inc. | 3.60B | 0.25% | 630,766 | 5.69B |
| 202 | GRAL | GRAIL, Inc. | 3.57B | -3.09% | 392,799 | 165.26M |
| 203 | VCYT | Veracyte, Inc. | 3.52B | -3.35% | 281,228 | 561.90M |
| 204 | NHC | National HealthCare Corporation | 3.49B | 0.33% | 129,464 | 1.56B |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.43B | -0.88% | 158,709 | 1.19M |
| 206 | QURE | uniQure N.V. | 3.37B | -1.84% | 583,780 | 18.67M |
| 207 | GPCR | Structure Therapeutics Inc. | 3.36B | -4.28% | 64,377 | - |
| 208 | WRBY | Warby Parker Inc. | 3.14B | 0.51% | 837,220 | 911.61M |
| 209 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | -0.67% | 305,764 | 606.33M |
| 210 | IMNM | Immunome, Inc. | 3.13B | -4.47% | 442,039 | 4.02M |
| 211 | CLDX | Celldex Therapeutics, Inc. | 3.10B | -2.47% | 226,925 | 158.00K |
| 212 | TMDX | TransMedics Group, Inc. | 3.09B | -2.83% | 399,307 | 668.47M |
| 213 | IRON | Disc Medicine, Inc. | 3.07B | -3.13% | 480,715 | - |
| 214 | MBX | MBX Biosciences, Inc. | 3.06B | -4.21% | 182,243 | - |
| 215 | NAMS | NewAmsterdam Pharma Company N.V. | 3.06B | -4.48% | 741,726 | 7.12M |
| 216 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -4.10% | 988,397 | 463.98M |
| 217 | BEAM | Beam Therapeutics Inc. | 2.94B | -3.58% | 932,738 | 156.04M |
| 218 | ZLAB | Zai Lab Limited | 2.92B | -2.93% | 90,484 | 449.61M |
| 219 | ALMS | Alumis Inc. | 2.92B | -2.74% | 354,017 | 7.40M |
| 220 | AVAH | Aveanna Healthcare Holdings Inc. | 2.92B | -3.22% | 1,435,319 | 2.60B |
| 221 | ALHC | Alignment Healthcare, Inc. | 2.86B | 1.77% | 1,872,294 | 4.58B |
| 222 | BKD | Brookdale Senior Living Inc. | 2.83B | -1.86% | 1,518,757 | 2.93B |
| 223 | AXGN | Axogen, Inc. | 2.77B | -0.29% | 360,203 | 251.17M |
| 224 | RGC | Regencell Bioscience Holdings Limited | 2.74B | 0.27% | 50,133 | - |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.73B | -2.07% | 471,260 | 36.77M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.73B | -11.11% | 7,663,914 | - |
| 227 | ATAI | AtaiBeckley Inc. | 2.72B | -0.14% | 1,797,361 | 4.47M |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.66B | -5.29% | 656,249 | 3.37B |
| 229 | PRVA | Privia Health Group, Inc. | 2.66B | -0.05% | 433,961 | 2.36B |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.63B | -2.81% | 417,257 | 71.13M |
| 231 | CDNA | CareDx, Inc. | 2.60B | -3.99% | 809,281 | 458.09M |
| 232 | WGS | GeneDx Holdings Corp. | 2.58B | -3.01% | 283,993 | 454.43M |
| 233 | NEOG | Neogen Corporation | 2.54B | -0.60% | 463,228 | 870.40M |
| 234 | SUPN | Supernus Pharmaceuticals, Inc. | 2.54B | -1.24% | 285,864 | 830.44M |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.52B | -2.40% | 714,157 | 717.00M |
| 236 | PHVS | Pharvaris N.V. | 2.51B | -3.35% | 350,509 | - |
| 237 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | -0.51% | 1,470,155 | 940.61M |
| 238 | PGEN | Precigen, Inc. | 2.50B | -2.78% | 1,837,270 | 85.72M |
| 239 | ATRC | AtriCure, Inc. | 2.48B | -0.87% | 52,289 | 569.62M |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | 2.29% | 51,304 | 1.10B |
| 241 | NKTR | Nektar Therapeutics | 2.45B | -3.86% | 257,965 | 54.59M |
| 242 | VERA | Vera Therapeutics, Inc. | 2.45B | -1.88% | 768,460 | - |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.40B | -6.35% | 1,433,688 | - |
| 244 | KOD | Kodiak Sciences Inc. | 2.37B | -3.43% | 209,063 | - |
| 245 | BHC | Bausch Health Companies Inc. | 2.36B | 0.32% | 869,557 | 10.85B |
| 246 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | -0.16% | 80,908 | 1.46B |
| 247 | RAPP | Rapport Therapeutics, Inc. | 2.34B | -3.97% | 196,567 | 20.00M |
| 248 | UFPT | UFP Technologies, Inc. | 2.34B | 0.77% | 12,186 | 631.64M |
| 249 | NUVB | Nuvation Bio Inc. | 2.34B | -4.72% | 2,685,300 | 169.90M |
| 250 | NEO | NeoGenomics, Inc. | 2.33B | -2.58% | 1,109,578 | 766.30M |
| 251 | BFLY | Butterfly Network, Inc. | 2.29B | -1.20% | 2,861,745 | 112.14M |
| 252 | MESO | Mesoblast Limited | 2.29B | -4.18% | 186,496 | 120.25M |
| 253 | BHVN | Biohaven Ltd. | 2.29B | -6.02% | 1,862,256 | - |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | -1.61% | 263,932 | 959.90M |
| 255 | OCUL | Ocular Therapeutix, Inc. | 2.28B | -3.97% | 1,011,374 | 52.06M |
| 256 | TRLV | Trulieve Cannabis Corp. | 2.26B | 6.62% | 1,030,309 | 1.14B |
| 257 | CLOV | Clover Health Investments, Corp. | 2.26B | 0.71% | 1,860,541 | 2.48B |
| 258 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | -2.27% | 410,448 | - |
| 259 | XRAY | DENTSPLY SIRONA Inc. | 2.23B | 1.36% | 1,715,745 | 3.64B |
| 260 | SRPT | Sarepta Therapeutics, Inc. | 2.23B | -2.32% | 2,440,246 | 1.97B |
| 261 | KLRA | Kailera Therapeutics, Inc. | 2.19B | -8.77% | 305,459 | - |
| 262 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -0.88% | 343,439 | 311.51M |
| 263 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.41% | 145,517 | - |
| 264 | HCM | HUTCHMED (China) Limited | 2.16B | -0.36% | 6,681 | 549.12M |
| 265 | URGN | UroGen Pharma Ltd. | 2.15B | -3.41% | 372,782 | 188.73M |
| 266 | ALMR | Alamar Biosciences, Inc. | 2.14B | -6.74% | 172,335 | 100.42M |
| 267 | COAG | Hemab Therapeutics Holdings, Inc. | 2.13B | -7.66% | 161,835 | - |
| 268 | NBTX | Nanobiotix S.A. | 2.13B | -7.91% | 151,400 | 38.27M |
| 269 | ADUS | Addus HomeCare Corporation | 2.13B | -1.44% | 124,761 | 1.48B |
| 270 | MD | Pediatrix Medical Group, Inc. | 2.11B | -0.52% | 428,168 | 1.95B |
| 271 | VCEL | Vericel Corporation | 2.11B | 0.24% | 288,015 | 306.30M |
| 272 | ESTA | Establishment Labs Holdings Inc. | 2.11B | -1.30% | 131,803 | 245.82M |
| 273 | ADMA | ADMA Biologics, Inc. | 2.10B | -0.95% | 710,545 | 512.28M |
| 274 | NVCR | NovoCure Limited | 2.07B | -1.33% | 396,596 | 699.19M |
| 275 | ZBIO | Zenas BioPharma, Inc. | 2.07B | -2.85% | 107,551 | 1.00M |
| 276 | STOK | Stoke Therapeutics, Inc. | 2.06B | -2.18% | 499,398 | 27.59M |
| 277 | ZYME | Zymeworks Inc. | 2.02B | -1.65% | 221,159 | 37.13M |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | -1.98% | 265,488 | 98.34M |
| 279 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.00B | -7.77% | 3,672,331 | 208.78M |
| 280 | PRGO | Perrigo Company plc | 2.00B | 0.31% | 1,355,947 | 4.14B |
| 281 | PGNY | Progyny, Inc. | 2.00B | 0.70% | 464,265 | 1.31B |
| 282 | GENB | Generate Biomedicines, Inc. | 1.98B | -2.35% | 1,988,616 | 26.48M |
| 283 | ASTH | Astrana Health, Inc. | 1.95B | -0.78% | 194,031 | 3.84B |
| 284 | XNCR | Xencor, Inc. | 1.94B | -9.70% | 1,084,232 | 104.97M |
| 285 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 1,400,110 | - |
| 286 | GHRS | GH Research PLC | 1.93B | -2.09% | 70,672 | - |
| 287 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -2.34% | 113,332 | 1.13B |
| 288 | CMPS | COMPASS Pathways plc | 1.90B | -6.18% | 1,679,262 | - |
| 289 | KARD | Kardigan, Inc. | 1.88B | -3.32% | 124,025 | - |
| 290 | IMCR | Immunocore Holdings plc | 1.88B | -0.79% | 209,302 | 430.78M |
| 291 | TSHA | Taysha Gene Therapies, Inc. | 1.87B | -3.52% | 1,513,854 | 5.49M |
| 292 | INBX | Inhibrx Biosciences, Inc. | 1.85B | 1.65% | 155,896 | 1.30M |
| 293 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 1.26% | 112,646 | 262.43M |
| 294 | VIR | Vir Biotechnology, Inc. | 1.84B | -3.71% | 1,298,198 | 303.23M |
| 295 | SEPN | Septerna, Inc. | 1.83B | -3.39% | 135,242 | 98.88M |
| 296 | PSNL | Personalis, Inc. | 1.81B | 1.07% | 1,925,918 | 69.67M |
| 297 | BRVE | Braveheart Bio, Inc. | 1.81B | 1.26% | 103,425 | - |
| 298 | NTLA | Intellia Therapeutics, Inc. | 1.80B | -1.79% | 2,528,208 | 59.51M |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.79B | -2.96% | 432,624 | 481.07M |
| 300 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -2.91% | 7,992,700 | 54.86M |
| 301 | BLFS | BioLife Solutions, Inc. | 1.78B | -2.02% | 478,822 | 106.69M |
| 302 | INSP | Inspire Medical Systems, Inc. | 1.78B | 1.32% | 148,085 | 898.74M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.78B | -0.77% | 524,307 | 2.68B |
| 304 | ALVO | Alvotech | 1.77B | 1.64% | 639,890 | 494.61M |
| 305 | SGRY | Surgery Partners, Inc. | 1.77B | -2.15% | 736,618 | 3.37B |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.76B | -6.76% | 152,313 | - |
| 307 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -3.32% | 524,406 | 252.25M |
| 308 | ETON | Eton Pharmaceuticals, Inc. | 1.70B | -4.83% | 427,934 | 105.60M |
| 309 | APMD | Apnimed, Inc. | 1.69B | 6.13% | 420,038 | 120.15M |
| 310 | ANAB | AnaptysBio, Inc. | 1.65B | -2.87% | 200,580 | 232.39M |
| 311 | AAPG | Ascentage Pharma Group International | 1.65B | -4.59% | 269 | 94.61M |
| 312 | FRNM | Freenome, Inc. | 1.60B | 6.74% | 1,287,842 | 35.41M |
| 313 | ANIP | ANI Pharmaceuticals, Inc. | 1.57B | -0.31% | 225,340 | 978.38M |
| 314 | LTGO | Latigo Biotherapeutics, Inc. | 1.57B | -0.80% | 104,126 | - |
| 315 | LBRX | LB Pharmaceuticals Inc | 1.57B | 1.36% | 144,953 | - |
| 316 | BCAX | Bicara Therapeutics Inc. | 1.56B | -5.11% | 257,564 | - |
| 317 | PAHC | Phibro Animal Health Corporation | 1.56B | 5.50% | 217,398 | 1.52B |
| 318 | AGL | agilon health, inc. | 1.56B | -1.57% | 22,741 | 5.92B |
| 319 | SLBT | SL Science Holding Limited | 1.55B | 2.65% | 5,547 | 3.27M |
| 320 | ARDT | Ardent Health, Inc. | 1.54B | -0.41% | 31,411 | 6.41B |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.54B | -1.57% | 520,299 | 335.41M |
| 322 | AVLN | Avalyn Pharma Inc. | 1.54B | -4.77% | 64,706 | - |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.54B | -2.44% | 365,143 | 1.86B |
| 324 | TRAX | First Tracks Biotherapeutics, Inc. | 1.53B | -4.11% | 234,631 | - |
| 325 | MAZE | Maze Therapeutics, Inc. | 1.53B | -3.74% | 126,654 | 20.00M |
| 326 | OMCL | Omnicell, Inc. | 1.52B | -0.39% | 217,349 | 1.25B |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.51B | 0.08% | 99,314 | 95.13M |
| 328 | INVA | Innoviva, Inc. | 1.51B | -0.10% | 296,945 | 440.00M |
| 329 | TYRA | Tyra Biosciences, Inc. | 1.51B | -3.33% | 107,528 | - |
| 330 | CNMD | CONMED Corporation | 1.50B | -0.20% | 109,792 | 1.37B |
| 331 | ABSI | Absci Corporation | 1.50B | -7.01% | 1,877,682 | 1.56M |
| 332 | TNDM | Tandem Diabetes Care, Inc. | 1.49B | 0.19% | 503,929 | 1.04B |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -2.52% | 177,976 | - |
| 334 | NVAX | Novavax, Inc. | 1.48B | -0.94% | 2,049,429 | 413.80M |
| 335 | REPL | Replimune Group, Inc. | 1.48B | 0.38% | 1,785,198 | - |
| 336 | INNV | InnovAge Holding Corp. | 1.47B | -1.54% | 81,339 | 949.17M |
| 337 | SDGR | Schrödinger, Inc. | 1.47B | -3.63% | 544,870 | 259.04M |
| 338 | OMDA | Omada Health, Inc. | 1.46B | -1.40% | 455,372 | 309.76M |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.46B | -1.31% | 605,221 | 815.05M |
| 340 | ENOV | Enovis Corporation | 1.45B | 1.13% | 176,256 | 2.30B |
| 341 | AZTA | Azenta, Inc. | 1.44B | -1.96% | 441,735 | 613.81M |
| 342 | AKTS | Aktis Oncology, Inc. | 1.43B | -1.45% | 200,641 | 10.06M |
| 343 | HROW | Harrow, Inc. | 1.40B | -2.88% | 268,562 | 275.59M |
| 344 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -3.58% | 396,296 | - |
| 345 | ANRO | Alto Neuroscience, Inc. | 1.39B | -2.64% | 166,490 | - |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.38B | -3.42% | 391,430 | - |
| 347 | OMER | Omeros Corporation | 1.36B | -2.44% | 739,596 | 38.42M |
| 348 | DRTS | Alpha Tau Medical Ltd. | 1.36B | -0.81% | 380,067 | - |
| 349 | SVRA | Savara Inc. | 1.35B | -3.28% | 829,503 | - |
| 350 | JBIO | Jade Biosciences, Inc. | 1.34B | -1.08% | 198,736 | - |
| 351 | AMN | AMN Healthcare Services, Inc. | 1.34B | -1.45% | 96,617 | 3.43B |
| 352 | IART | Integra LifeSciences Holdings Corporation | 1.33B | 1.66% | 268,653 | 1.65B |
| 353 | VOR | Vor Biopharma Inc. | 1.33B | -4.63% | 267,700 | - |
| 354 | NUTX | Nutex Health Inc. | 1.32B | -0.54% | 27,073 | 846.72M |
| 355 | AORT | Artivion, Inc. | 1.32B | 1.31% | 197,706 | 471.47M |
| 356 | MGTX | MeiraGTx Holdings plc | 1.32B | -3.04% | 585,319 | 397.50M |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.31B | -6.90% | 97,776 | - |
| 358 | PNTG | The Pennant Group, Inc. | 1.30B | -1.27% | 40,692 | 1.10B |
| 359 | IMTX | Immatics N.V. | 1.29B | 0.85% | 780,896 | 47.65M |
| 360 | MLTX | MoonLake Immunotherapeutics | 1.28B | -2.87% | 445,126 | - |
| 361 | CERT | Certara, Inc. | 1.28B | -0.48% | 673,216 | 421.75M |
| 362 | MNKD | MannKind Corporation | 1.27B | -2.59% | 1,135,377 | 393.63M |
| 363 | CRON | Cronos Group Inc. | 1.25B | -0.29% | 1,042,339 | 179.09M |
| 364 | GDRX | GoodRx Holdings, Inc. | 1.22B | 1.71% | 734,925 | 785.23M |
| 365 | ODTX | Odyssey Therapeutics, Inc. | 1.19B | -4.39% | 20,595 | 99.00K |
| 366 | TDOC | Teladoc Health, Inc. | 1.19B | 2.91% | 2,274,317 | 2.49B |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.18B | 0.39% | 337,687 | 337.34M |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -4.48% | 294,243 | - |
| 369 | SANA | Sana Biotechnology, Inc. | 1.18B | -3.91% | 1,636,224 | - |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.58% | 55,071 | 804.27M |
| 371 | IVA | Inventiva S.A. | 1.17B | -3.98% | 712,548 | 7.94M |
| 372 | BVS | Bioventus Inc. | 1.17B | 0.58% | 263,397 | 581.85M |
| 373 | GLUE | Monte Rosa Therapeutics, Inc. | 1.15B | -5.52% | 534,132 | 28.73M |
| 374 | KURA | Kura Oncology, Inc. | 1.13B | -3.57% | 1,198,752 | 77.23M |
| 375 | IRMD | IRADIMED CORPORATION | 1.12B | 0.82% | 30,357 | 86.34M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.85% | 246,601 | 1.04B |
| 377 | OPK | OPKO Health, Inc. | 1.11B | -1.00% | 1,719,970 | 587.90M |
| 378 | STAA | STAAR Surgical Company | 1.11B | -1.47% | 260,069 | 339.59M |
| 379 | JANX | Janux Therapeutics, Inc. | 1.11B | -3.73% | 392,150 | 24.00M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.05B | -1.90% | 484,768 | 59.00K |
| 381 | SLDB | Solid Biosciences Inc. | 1.05B | -3.06% | 366,800 | - |
| 382 | QDEL | QuidelOrtho Corporation | 1.02B | -2.55% | 750,515 | 2.67B |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.02B | -0.58% | 245,144 | 746.16M |
| 384 | CSTL | Castle Biosciences, Inc. | 1.01B | -3.06% | 154,161 | 357.28M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.01B | -1.72% | 2,072,994 | 41.47M |
| 386 | ABUS | Arbutus Biopharma Corporation | 1.01B | -1.16% | 2,548,212 | 181.72M |
| 387 | WVE | Wave Life Sciences, Inc. | 1.00B | -1.55% | 1,425,055 | 65.37M |
| 388 | CADL | Candel Therapeutics, Inc. | 996.27M | -5.31% | 932,197 | - |
| 389 | IMMX | Immix Biopharma, Inc. | 995.11M | -2.80% | 760,603 | - |
| 390 | GMRS | GMR Solutions Inc. | 987.07M | 1.03% | 142,302 | 5.88B |
| 391 | GERN | Geron Corporation | 966.92M | -1.63% | 3,471,224 | 204.56M |
| 392 | ARDX | Ardelyx, Inc. | 953.14M | 0.13% | 3,727,794 | 450.89M |
| 393 | DSGN | Design Therapeutics, Inc. | 951.24M | -0.33% | 531,659 | - |
| 394 | ANNX | Annexon, Inc. | 942.21M | -5.33% | 914,793 | - |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 938.39M | 0.82% | 122,974 | 730.02M |
| 396 | GLAS | Glass House Brands Inc. | 928.29M | 0.72% | 424,230 | 176.98M |
| 397 | CBLL | CeriBell, Inc. | 905.34M | 0.94% | 122,310 | 101.96M |
| 398 | BBNX | Beta Bionics, Inc. | 893.05M | 1.59% | 442,708 | 119.01M |
| 399 | OLMA | Olema Pharmaceuticals, Inc. | 892.48M | -5.47% | 380,411 | - |
| 400 | HELP | Cybin Inc. | 892.06M | -7.78% | 1,215,629 | - |
| 401 | TBPH | Theravance Biopharma, Inc. | 884.70M | - | 204,266 | 104.31M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 884.67M | -2.44% | 771,161 | 8.22M |
| 403 | ANL | Adlai Nortye Group Ltd. | 884.18M | -4.12% | 135,105 | 18.06M |
| 404 | ATTO | Attovia Therapeutics, Inc. | 882.96M | -4.38% | 19,762 | 1.35M |
| 405 | FTH | Faeth Therapeutics, Inc. | 882.45M | 1.22% | 215,502 | - |
| 406 | SGP | SpyGlass Pharma, Inc. | 875.33M | -2.82% | 47,180 | - |
| 407 | AVR | Anteris Technologies Global Corp. | 867.38M | -0.78% | 266,948 | 2.24M |
| 408 | RIGL | Rigel Pharmaceuticals, Inc. | 867.31M | -0.92% | 92,085 | 276.79M |
| 409 | SIBN | SI-BONE, Inc. | 866.34M | 0.68% | 229,769 | 213.60M |
| 410 | HSTM | HealthStream, Inc. | 857.90M | 1.77% | 27,956 | 321.12M |
| 411 | INMD | InMode Ltd. | 856.18M | 0.37% | 263,468 | 374.63M |
| 412 | CLYM | Climb Bio, Inc. | 852.35M | -1.46% | 584,577 | - |
| 413 | PHAR | Pharming Group N.V. | 832.78M | -1.27% | 1,384 | 366.48M |
| 414 | ACHV | Achieve Life Sciences, Inc. | 829.39M | -1.47% | 755,815 | - |
| 415 | COLL | Collegium Pharmaceutical, Inc. | 828.21M | -3.78% | 483,967 | 808.21M |
| 416 | DBVT | DBV Technologies S.A. | 815.25M | -6.18% | 123,326 | 5.04M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 798.83M | -3.02% | 774,098 | 92.01M |
| 418 | SLN | Silence Therapeutics plc | 797.17M | -1.56% | 298,448 | 615.00K |
| 419 | AHCO | AdaptHealth Corp. | 781.78M | 1.03% | 863,912 | 3.36B |
| 420 | VREX | Varex Imaging Corporation | 779.95M | 0.08% | 390,386 | 865.00M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 777.88M | -5.22% | 97,845 | - |
| 422 | AURA | Aura Biosciences, Inc. | 774.67M | -2.99% | 51,417 | - |
| 423 | CBIO | Crescent Biopharma, Inc. | 761.43M | 0.17% | 37,590 | 11.88M |
| 424 | OCS | Oculis Holding AG | 760.54M | -0.88% | 131,913 | 1.45M |
| 425 | PHR | Phreesia, Inc. | 749.16M | 2.19% | 238,626 | 495.59M |
| 426 | MNPR | Monopar Therapeutics Inc. | 736.66M | -3.68% | 151,625 | - |
| 427 | NGNE | Neurogene Inc. | 736.02M | -2.85% | 24,749 | 925.00K |
| 428 | DRUG | Bright Minds Biosciences Inc. | 732.33M | -1.97% | 67,414 | - |
| 429 | AHG | Akso Health Group | 729.65M | -13.09% | 12,662 | 13.83M |
| 430 | PHAT | Phathom Pharmaceuticals, Inc. | 725.20M | 2.13% | 405,642 | 239.66M |
| 431 | STTK | Shattuck Labs, Inc. | 713.58M | -7.06% | 383,772 | 1.00M |
| 432 | CTMX | CytomX Therapeutics, Inc. | 712.53M | -4.39% | 1,394,620 | 18.30M |
| 433 | OBX | Obsidian Therapeutics, Inc. | 708.39M | -4.05% | 247,249 | - |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 703.13M | -4.47% | 126,453 | - |
| 435 | SSII | SS Innovations International, Inc. | 699.35M | 2.05% | 1,366 | 52.40M |
| 436 | ALLO | Allogene Therapeutics, Inc. | 697.89M | -3.35% | 672,164 | 4.64M |
| 437 | SOPH | SOPHiA GENETICS SA | 696.35M | -8.30% | 306,668 | 86.17M |
| 438 | GYRE | Gyre Therapeutics, Inc. | 696.11M | -1.72% | 7,344 | 109.82M |
| 439 | MPLT | MapLight Therapeutics, Inc. | 693.58M | -0.48% | 214,302 | - |
| 440 | TECX | Tectonic Therapeutic, Inc. | 692.05M | -3.54% | 116,611 | - |
| 441 | EVO | Evotec SE | 690.62M | -3.05% | 3,829 | 819.47M |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 687.07M | -2.36% | 122,118 | 136.07M |
| 443 | ASMB | Assembly Biosciences, Inc. | 685.74M | -3.22% | 145,660 | 74.85M |
| 444 | IRWD | Ironwood Pharmaceuticals, Inc. | 682.44M | -2.59% | 975,350 | 389.32M |
| 445 | SGMT | Sagimet Biosciences Inc. | 660.12M | -1.21% | 357,405 | - |
| 446 | VSTM | Verastem, Inc. | 658.85M | -1.42% | 555,896 | 87.53M |
| 447 | ANGO | AngioDynamics, Inc. | 656.77M | 0.70% | 106,988 | 320.17M |
| 448 | MDXG | MiMedx Group, Inc. | 655.19M | -0.33% | 538,021 | 355.17M |
| 449 | OABI | OmniAb, Inc. | 653.53M | -2.49% | 730,188 | 38.46M |
| 450 | CTEV | Claritev Corporation | 650.78M | -0.98% | 60,631 | 994.67M |
| 451 | PRME | Prime Medicine, Inc. | 647.57M | - | 2,158,224 | 4.07M |
| 452 | CRMD | CorMedix Inc. | 646.94M | -0.12% | 459,746 | 462.25M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 646.90M | -0.32% | 109,941 | - |
| 454 | AGMB | AgomAb Therapeutics NV | 646.38M | -5.17% | 208,248 | - |
| 455 | AQST | Aquestive Therapeutics, Inc. | 635.09M | -1.94% | 1,968,725 | 54.09M |
| 456 | STLN | Starling Oncology, Inc. | 631.88M | -2.21% | 547,198 | 587.24M |
| 457 | TLRY | Tilray Brands, Inc. | 630.61M | 1.75% | 2,895,874 | 915.45M |
| 458 | RGNX | REGENXBIO Inc. | 629.11M | 1.71% | 1,134,742 | 174.48M |
| 459 | VALN | Valneva SE | 621.92M | -1.22% | 2,256 | 163.30M |
| 460 | AUTL | Autolus Therapeutics plc | 620.16M | -1.27% | 1,136,721 | 117.39M |
| 461 | KIDS | OrthoPediatrics Corp. | 618.54M | 1.59% | 30,483 | 252.72M |
| 462 | CTKB | Cytek Biosciences, Inc. | 604.42M | 0.65% | 368,018 | 206.71M |
| 463 | ALT | Altimmune, Inc. | 603.00M | -4.32% | 2,348,476 | 31.00K |
| 464 | BLSM | BlossomHill Therapeutics, Inc. | 601.23M | -0.91% | 29,615 | - |
| 465 | EIKN | Eikon Therapeutics, Inc. | 596.36M | -4.43% | 159,501 | - |
| 466 | ARVN | Arvinas, Inc. | 595.01M | -1.52% | 380,926 | 316.70M |
| 467 | SPRY | ARS Pharmaceuticals, Inc. | 585.74M | -2.32% | 666,412 | 116.93M |
| 468 | EOLS | Evolus, Inc. | 584.55M | -0.34% | 661,637 | 316.49M |
| 469 | WEAV | Weave Communications, Inc. | 584.39M | 0.07% | 1,274,609 | 257.79M |
| 470 | PRLD | Prelude Therapeutics Incorporated | 582.95M | -10.73% | 562,942 | 22.42M |
| 471 | BWAY | BrainsWay Ltd. | 579.92M | -0.69% | 10,900 | 60.70M |
| 472 | DCTH | Delcath Systems, Inc. | 567.67M | -0.18% | 294,870 | 95.42M |
| 473 | CAPR | Capricor Therapeutics, Inc. | 558.72M | -4.47% | 3,869,068 | 11.13M |
| 474 | PROK | ProKidney Corp. | 551.74M | 0.27% | 993,279 | 818.00K |
| 475 | OVID | Ovid Therapeutics Inc. | 550.74M | -3.75% | 1,095,648 | 1.58M |
| 476 | SCTX | Scribe Therapeutics Inc. | 550.37M | 1.16% | 174,118 | 36.28M |
| 477 | ZURA | Zura Bio Limited | 546.23M | -2.56% | 1,474,856 | - |
| 478 | FLGT | Fulgent Genetics, Inc. | 543.43M | -1.00% | 97,645 | 323.93M |
| 479 | ARTV | Artiva Biotherapeutics, Inc. | 542.68M | -7.04% | 51,310 | 251.00K |
| 480 | CABA | Cabaletta Bio, Inc. | 540.00M | -5.77% | 2,562,943 | - |
| 481 | CERS | Cerus Corporation | 538.07M | -1.84% | 1,156,920 | 221.55M |
| 482 | TCMD | Tactile Systems Technology, Inc. | 527.57M | 0.78% | 151,406 | 350.31M |
| 483 | SRTA | Strata Critical Medical, Inc. | 525.05M | -3.81% | 387,743 | 255.98M |
| 484 | EVH | Evolent Health, Inc. | 524.60M | 1.09% | 1,539,461 | 2.10B |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 523.81M | -1.97% | 363,172 | - |
| 486 | ENTX | Entera Bio Ltd. | 523.75M | -1.79% | 16,368 | 42.00K |
| 487 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 488 | NPCE | NeuroPace, Inc. | 497.36M | 2.55% | 72,022 | 106.99M |
| 489 | EDIT | Editas Medicine, Inc. | 494.53M | -2.42% | 2,669,374 | 47.01M |
| 490 | SENS | Senseonics Holdings, Inc. | 493.31M | -0.74% | 240,455 | 48.55M |
| 491 | NRC | NRC Health | 489.17M | 0.48% | 11,188 | 140.00M |
| 492 | EPRX | Eupraxia Pharmaceuticals Inc. | 483.51M | -8.22% | 55,501 | - |
| 493 | RZLT | Rezolute, Inc. | 478.98M | -7.93% | 661,905 | - |
| 494 | CCCC | C4 Therapeutics, Inc. | 477.95M | -5.24% | 1,324,036 | 35.04M |
| 495 | PRTA | Prothena Corporation plc | 475.89M | 1.98% | 283,500 | 54.53M |
| 496 | CLPT | ClearPoint Neuro, Inc. | 474.65M | -2.38% | 303,630 | 42.28M |
| 497 | KMDA | Kamada Ltd. | 472.40M | 0.24% | 10,155 | 191.85M |
| 498 | EVMN | Evommune, Inc. | 471.43M | -3.64% | 166,914 | 10.00M |
| 499 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.69M | -4.13% | 828,392 | 132.42M |
| 500 | PBYI | Puma Biotechnology, Inc. | 468.19M | -1.84% | 28,956 | 231.24M |